Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies
Clinical trial NCT02328014 · COMPLETED
Trial details
- NCT number
- NCT02328014
- Sponsor
- Acerta Pharma BV
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-20
- Primary completion
- 2020-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.